
    
      Total anticipated: 300 subjects (150/group). 2-dose group - 10-valent pneumococcal vaccine +
      DTPa combined vaccine (2, 4, 11 months); Comparator group - 10-valent pneumococcal vaccine
      (2, 3, 4, 11 months) + DTPa combined vaccine (2, 4, 11 months). The Protocol Posting has been
      updated in order to comply with the FDA Amendment Act, Sep 2007.
    
  